Drug delivery, disposition and dynamics (D4)

Drug Delivery, Disposition and Dynamics

The Drug delivery, disposition and dynamics (D4) research teams within the Monash Institute of Pharmaceutical Sciences (MIPS) are designing and developing the next generation of drug delivery systems and anti-infective agents to enhance medicine effectiveness and patient treatment.

Ben Boyd

Research areas

Find a researcher



Contact us

+61 3 9903 9614
nicki.penny@monash.edu

Find a D4 PhD project

We're looking for the brightest biomedical science, pharmaceutical science and pharmacy talent to join our ambitious, curious and groundbreaking research teams. We want to change the world and you can help us.

Find out more

See the latest news

Search news

Browse by category

Browse: ▾

Select all - Clear all

Monash University retains its spot as #2 in the world for Pharmacy and Pharmacology

The 2021 QS World University Rankings by Subject, released today, ranked Monash University number two in the world for Pharmacy and Pharmacology for the second year running.
lymphatic

Monash University and PureTech Health develop novel technology platform that targets drugs to the lymphatics and lymph nodes

Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS) and PureTech Health (LSE: PRTC, Nasdaq: PRTC) have developed a novel technology platform that directly targets gut lymphatics and has great potential to enhance the utility of

Researchers from Monash University make a breakthrough discovery into how migraines are triggered

World first: Researchers from Monash University have harnessed cutting-edge technology to discover the progression of molecular events that lead to migraine – something that, until now, has remained a mystery.

Collaboration between Monash and Auckland Universities find obesity drug could treat severe acute diseases

Researchers from the Monash Institute of Pharmaceutical Sciences (MIPS), in collaboration with researchers at the Surgical and Translational Research (STaR) Centre at the University of Auckland, have found that a common medication used to treat

Scientists use tumour tissue from cancer patients to enhance testing of nanomedicines

In an important advance for the field of nanomedicine and the treatment of cancer, a team of scientists led from the Monash Institute of Pharmaceutical Sciences (MIPS) have used tumour tissue from cancer patients to better discriminate between

MIPS researcher receives grant from MS Research Australia

Professor Jonathan Baell from the Medicinal Chemistry theme of the Monash Institute of Pharmaceutical Sciences (MIPS) has been awarded a Project Grant from MS Research Australia to develop a new test to monitor multiple sclerosis (MS) disease

Vale John Ware OAM

Respected alumnus, community pharmacist, international leader in the pharmacy profession, long-time friend and generous supporter of our Faculty, Mr. John Alexander Ware, passed away on 27th December 2020, aged nearly 93.

Prof. Bill Charman named an Officer of the Order of Australia (AO)

Prof. William (Bill) Neil Charman of the Faculty of Pharmacy and Pharmaceutical Sciences has been announced as an Officer of the Order of Australia (AO), General Division, by the Governor-General in the 2021 Australia

Monica Jung and Helena Cangadis-Douglass awarded MARC-CMUS PhD Scholarships to address the global priority of opioid misuse

Monash Health pharmacist Monica Jung and Austin Health pharmacist Helena Cangadis-Douglass have been awarded the inaugural Monash Addiction Research Centre (MARC) - Centre for Medicine Use and Safety (CMUS) Scholarships for PhD research into safe